VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

9475	Companies
185442	Keywords
117781	Articles
99296	Press releases

Home
Companies
VALNEVA

BRIEF

published on 12/03/2025 at 11:03, 2 days ago

Valneva SE: Promising Developments in Lyme Disease Vaccine

Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15
PRESS RELEASE

published on 12/03/2025 at 10:58, 2 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation for Valneva SE, raising target price to €6.80. VLA15 vaccine progress and market potential analyzed

Buy Recommendation Research Update Valneva SE Market Potential VLA15 Vaccine
BRIEF

published on 11/04/2025 at 07:05, 1 month 1 day ago

Valneva's Phase 1 Trial Yields Positive Results for Zika Vaccine

Phase 1 Trial Valneva Immunogenicity Zika Vaccine Adjuvant
PRESS RELEASE

published on 11/04/2025 at 07:00, 1 month 1 day ago

Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial

Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine
BRIEF

published on 10/09/2025 at 16:04, 1 month 26 days ago

Bpifrance Crosses Threshold in the Capital of Valneva SE

Stock Market Valneva SE Threshold Crossing Bpifrance Deposit Fund
BRIEF

published on 10/06/2025 at 07:35, 1 month 30 days ago

Valneva Updates on Shares and Voting Rights

Voting Rights Shares Euronext Valneva France
PRESS RELEASE

published on 10/06/2025 at 07:30, 1 month 30 days ago

VALNEVA Declaration of shares and voting rights: September 30, 2025
Valneva declares transfer into bearer form of 653 shares with double voting rights and grants double voting rights on 100 ordinary shares, affecting total voting rights

Voting Rights Valneva Shares Transfer Double Rights Bearer Form
BRIEF

published on 09/03/2025 at 07:05, 3 months 2 days ago

Valneva's Lyme Disease Vaccine Makes Significant Progress

Valneva Safety Phase 2 Lyme Vaccine Immunogenicity
BRIEF

published on 08/26/2025 at 11:30, 3 months 9 days ago

Valneva's Stock Outlook Amid Regulatory Challenges

Valneva SE Lyme Disease Chikungunya Vaccine Vaccine Market FDA Suspension
PRESS RELEASE

published on 08/26/2025 at 11:25, 3 months 9 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Valneva SE (ISIN: FR0004056851) with BUY rating & reduced target price to EUR 6.30. FDA suspends Valneva's chikungunya vaccine; VLA15 Lyme disease vaccine prospects remain positive

First Berlin Equity Research BUY Rating Valneva SE Chikungunya Vaccine Lyme Disease VLA15

1 2 ... 9

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 46 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 51 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours 21 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 16 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 21 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 11:14, 7 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 51 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 6 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 41 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 51 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 36 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours 21 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 36 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 37 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 4 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE